Mechanism of Duzhong Bushen Formula Regulating MAPK/AP-1 Pathway to Improve Lumbar Intervertebral Disc Degeneration: Evidencefrom Network Pharmacology and In Vivo Experiment in Rats
DBF may be a promising multi-target therapeutic agent for the treatment of IDD, particularly in cases involving kidney deficiency and blood stasis.
Authors
- Yao Zhou (ORCID: https://orcid.org/0000-0002-6527-9802)
- Ting Jiang (ORCID: https://orcid.org/0000-0002-6847-0020)
- Hao Lv (ORCID: https://orcid.org/0000-0001-6758-8492)
- Yán Wāng (ORCID: https://orcid.org/0000-0002-2940-3300)
- Xingyu Wang
- Yi Wang (ORCID: https://orcid.org/0000-0002-2067-5465)
- Lei Shi (ORCID: https://orcid.org/0009-0003-8190-7711)
- Yinghao Zhu
- Qingsong Chu
Institutions
- Anhui University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Combinatorial Chemistry & High Throughput Screening
- Published
- 2025-11-05
- DOI
- https://doi.org/10.2174/0113862073409567251008054328
- Primary Topic
- Spine and Intervertebral Disc Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00